← FDA DRUG APPROVALS

FDA ANDA · ANDA203576

LEVOLEUCOVORIN CALCIUM

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA203576
TYPE
ANDA
ORIGINAL APPROVAL
2015-10-20
LATEST ACTION
2017-01-06
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

LEVOLEUCOVORIN CALCIUMDiscontinued
LEVOLEUCOVORIN CALCIUM EQ 250MG BASE/25ML (EQ 10MG BASE/ML) · SOLUTION · INTRAVENOUS
LEVOLEUCOVORIN CALCIUMDiscontinued
LEVOLEUCOVORIN CALCIUM EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) · SOLUTION · INTRAVENOUS

Approval history

2017-01-06Labeling · Supplement 1 · standardAP
2015-10-20UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →